Medicenna Therapeutics Corp. Email Format

Biotechnology ResearchOntario, Canada11-50 Employees

Medicenna Therapeutics Corp. is a clinical-stage biotechnology company based in Toronto, Ontario, focused on developing immunotherapies for cancer and inflammatory diseases. It works on engineered cytokines designed to broaden treatment options by modulating the immune system. Lead programs include Bizaxofusp for glioblastoma, an IL-2–targeting therapy for metastatic cancers, and a PD-1 x IL-2 bispecific aimed at cancers expressing IL-13Rα2, with early-stage programs in autoimmune conditions such as asthma and COPD.

The therapies are intended for patients with cancer or autoimmune/inflammatory diseases and the clinicians who care for them. Medicenna operates within the biotechnology research industry and pursues global clinical development from its Toronto base. In 2026, Medicenna presented preclinical data at the AACR Annual Meeting.

Sign up for free to view info

Company overview Employee directory